When stressed, we ‘catastrophize’ – but we can learn to calm our irrational fears | Sophie Brickman
Our primitive brains summon up worst-case scenarios to protect us from danger. In today ’s world, that can be debilitatingThe first day I returned to work after maternity leave, I walked to the office racked with a fear I knew to be highly unlikely: that our new, and loving, caregiver would push the stroller across the street at the precise moment a reckless driver ran the light. I imagined the sound of tires screeching, the sickening crunch. I started to sweat, and my heart rate quickened. And then, when I got to the office, I took a deep breath, told myself to pull it together, and did.What I was doing, I later learned...
Source: Guardian Unlimited Science - June 21, 2022 Category: Science Authors: Sophie Brickman Tags: Health Psychology Source Type: news

Top Local Changemakers Addressing Health Equity Gaps Across the U.S. Named Johnson & Johnson Health Equity Innovation Challenge Awardees
NEW BRUNSWICK, N.J., June 14, 2022 – After an extensive search for the top changemakers in six key U.S. cities, Johnson & Johnson today announced the 14 awardees of its Health Equity Innovation Challenge. The awardees, who possess lived experience and a deep understanding of the communities they serve, were selected for their work in generating solutions to help close racial health and mortality gaps in six cities where Black and Brown individuals experience significant health inequities: Chicago, Detroit, Los Angeles, New Orleans, New York City and Philadelphia.The Health Equity Innovation Challenge was created by J...
Source: Johnson and Johnson - June 14, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Premature baby saved by CUDDLES from her mother
Elsie Dutton, who was born just 23 weeks old, is now back with her family in Barnsley, South Yorks in part thanks to a cuddling routine which helped stabilise her tiny heart. (Source: the Mail online | Health)
Source: the Mail online | Health - June 13, 2022 Category: Consumer Health News Source Type: news

AHA News: Tiny Sprouts Provide Big Nutrition
TUESDAY, June 7, 2022 (American Heart Association News) -- Move over baby carrots and petite peas. Even tinier vegetables are catching on as go-to healthy foods. Microscale vegetables, a growing food category that includes sprouted seeds, are... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 7, 2022 Category: General Medicine Source Type: news

Here ’s What to Know About COVID-19 Booster Shots for Kids
Children were always going to be the toughest group to vaccinate against COVID-19, so it’s no coincidence that they were the last group to receive authorization for the shot; manufacturers and government agencies want to be extra careful to find the right dosing and safety profile for the youngest Americans. The same is true for boosters. Here are answers to some frequently asked questions about boosters for kids. Which children are eligible for a booster? On May 19, the U.S. Centers for Disease Control and Prevention (CDC) expanded eligibility of the Pfizer-BioNTech booster for all Americans as young as age five and...
Source: TIME: Health - June 2, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Here ’ s What to Know About COVID-19 Booster Shots for Kids
Children were always going to be the toughest group to vaccinate against COVID-19, so it’s no coincidence that they were the last group to receive authorization for the shot; manufacturers and government agencies want to be extra careful to find the right dosing and safety profile for the youngest Americans. The same is true for boosters. Here are answers to some frequently asked questions about boosters for kids. Which children are eligible for a booster? On May 19, the U.S. Centers for Disease Control and Prevention (CDC) expanded eligibility of the Pfizer-BioNTech booster for all Americans as young as age five and...
Source: TIME: Health - June 2, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

New Data Show Patients Treated with First-in-Class TREMFYA ® (guselkumab) Achieve Durable Efficacy Across Joint and Axial Symptoms of Active Psoriatic Arthritis Through Two Years
SPRING HOUSE, PENNSYLVANIA, June 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from Phase 3 studies demonstrating patients treated with TREMFYA® (guselkumab) achieved consistent, long-term efficacy through two years across the domains of active psoriatic arthritis (PsA) – including joint, skin, enthesitis,a dactylitis,b spinal pain and disease severityc endpoints – irrespective of baseline characteristics.1 Further analyses showed TREMFYA also provided patients with sustained improvements in measures of health-related quality of life (HRQoL), including fatigue, pain...
Source: Johnson and Johnson - June 1, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Studying animal evolution to advance women ’s health
Breast cancer, osteoporosis and infertility don ’t just affect women — they also strike animals across the female tree of life.Yet many species have developed physical changes over millions of years that protect them from these conditions, begging the question: What if the key to preventing these and other disorders lies untapped in the animal king — er, queendom? That ’s the crux of a new UCLA paperpublished in PNAS Nexus that  summarizes years of research measuring females ’ risk for common diseases across different species. The authors — a physician, an evolutionary biologist and a veterinarian — teamed...
Source: UCLA Newsroom: Health Sciences - May 31, 2022 Category: Universities & Medical Training Source Type: news

COVID and Discrimination Aggravated Maternal Mortality in Latin America
Adequate maternal care during pregnancy, childbirth and the postpartum period is essential to curbing the high maternal mortality rates in Latin America, which stopped falling due to women's health care problems during the COVID pandemic. CREDIT: Government of Tigre / ArgentinaBy Mario OsavaRIO DE JANEIRO, May 27 2022 (IPS) Brazil had the dubious distinction of champion of maternal mortality in Latin America during the COVID-19 pandemic, with a 77 percent increase in such deaths between 2019 and 2021. A total of 1,575 women died in childbirth or in the following six weeks in the year prior to the pandemic in Latin America&...
Source: IPS Inter Press Service - Health - May 27, 2022 Category: International Medicine & Public Health Authors: Mario Osava Tags: COVID-19 Development & Aid Editors' Choice Featured Gender Headlines Health Latin America & the Caribbean Population Regional Categories TerraViva United Nations Women's Health Brazil Maternal Mortality Rate (MMR) Pan-American Source Type: news

Abbott plans to restart plant at the heart of the baby formula recall on June 4
Abbott Nutrition said Tuesday that it plans to restart work at the Sturgis, Michigan, plant at the heart of the nationwide baby formula recall on June 4, with the first batches of new formula expected to be available to consumers on or around June 20. (Source: CNN.com - Health)
Source: CNN.com - Health - May 25, 2022 Category: Consumer Health News Source Type: news

Janssen Presents Study Results Showing Clinical Efficacy for TREMFYA ® (guselkumab) and Long-Term Safety Profile for STELARA® (ustekinumab) for Patients Living with Inflammatory Bowel Disease at Digestive Disease Week® 2022
SPRING HOUSE, PENNSYLVANIA, May 24, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 2 GALAXI 1 clinical trial of TREMFYA® (guselkumab) in adult patients with moderately to severely active Crohn’s disease (CD), and from three separate long-term pooled analyses of adult patients with ulcerative colitis (UC) and CD treated with STELARA® (ustekinumab).1,2,3,4 These data are being presented as oral and poster presentations and are among 29 Janssen abstracts presented during the Digestive Disease Week® (DDW) meeting taking place in person and virtually in San Di...
Source: Johnson and Johnson - May 24, 2022 Category: Pharmaceuticals Source Type: news

New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition (DPI) with XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD)
RARITAN, N.J., May 23, 2022 – Findings from the XARELTO® (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and the XARELTO® in Combination with Acetylsalicylic Acid (XATOA) registry have been published in the European Society of Cardiology’s (ESC) European Heart Journal, Cardiovascular Pharmacotherapy. Additionally, the XATOA registry was presented at the American Congress of Cardiology’s 71st Annual Scientific Session (ACC.22). These studies provide further evidence supporting the role of dual pathway inhibition (DPI) with the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 100 mg...
Source: Johnson and Johnson - May 23, 2022 Category: Pharmaceuticals Source Type: news

Closed Baby Formula Plant May Reopen by Next Week
FRIDAY, May 20, 2022 -- A baby formula plant closed in February at the heart of the current U.S. shortage of the product could reopen as soon as next week, U.S. Food and Drug Administration Commissioner Robert Califf, M.D., told House lawmakers on... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 20, 2022 Category: Pharmaceuticals Source Type: news

New Data Show TREMFYA ® (guselkumab) Binds to Both Inflammatory Cells and Interleukin (IL)-23, Supporting a Hypothesis for a Differentiated Mechanism from Risankizumab
SPRING HOUSE, PENNSYLVANIA, May 18, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the first results of the in vitro MODIF-Y studies, supporting a hypothesis that may differentiate the mechanism of first-in-class TREMFYA® (guselkumab) from risankizumab due to the ability of TREMFYA to bind to CD64 positive (CD64+) cells in addition to interleukin (IL)-23 — both of which are key components of the immune system. 1,2 These findings, which are being presented at the Society for Investigative Dermatology (SID) annual meeting May 18-21, 2022 in Portland, Oregon, demonstrate TREMFYA bind...
Source: Johnson and Johnson - May 18, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Judge signs off on steps troubled baby formula manufacturer must take to restart closed plant
A federal judge has signed off on a legally binding agreement between the United States Food and Drug Administration and the baby formula manufacturer Abbott Nutrition, the company at the heart of a nationwide formula recall. (Source: CNN.com - Health)
Source: CNN.com - Health - May 18, 2022 Category: Consumer Health News Source Type: news